EGb 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders
NCT02321475
·
clinicaltrials.gov ↗
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class
Conditions
Cognitive Disorders
Interventions
DRUG:
EGb761®
Sponsor
Ipsen